logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Why are So Many Health Care Companies Moving to Ireland?

By  +Follow June 18, 2014 3:00AM
Share:
Tickers Mentioned:

Ireland, tax inversion, health care stocks, tax avoidance, overseas corporationsCovidien (COV) surged to a 52-week high of $86.75 per share on June 16, after rival medical device manufacturer Medtronic (MDT) announced it would buy the Irish company for $42.9 billion in a cash-and-stock deal. The combined company would have its executive offices in Dublin, but it would continue to stage most of its operations in Minneapolis, where Medtronic employs more than 8,000 people. Similarly, although Covidien is run from Mansfield, Massachusetts, it’s been incorporated in Ireland since 2009.

Why? It most likely comes down to the fact that the U.S. government has the highest corporate tax rate among developed nations at 35 percent. That’s what has many health care companies moving to Ireland. Or, at least, moving just enough of their operations there to avoid paying taxes in the United States.

Medtronic Not Alone

On top of Medtronic, there are more than 40 American companies that currently reincorporate in foreign countries or have plans to do so. In a recent wave of big moves, many health care companies have considered moving enough of their operations overseas to benefit from Ireland’s attractive 12.5% corporate tax rate.

Pfizer (PFE) , the largest U.S. drug maker, tried to acquire AstraZeneca (AZN) with a $117 billion bid in May 2014. The N.Y.-based company was seeking to lower its tax rate through the deal by moving its official headquarters to London, where AstraZeneca is based. While Pfizer was also planning to gain from AstraZeneca’s experimental immune therapy cancer drugs, a new class treatment that would have filled a hole in Pfizer’s product portfolio, it also seems certain the tax benefits were a major motivator.

The Pfizer deal failed when AstraZeneca shareholders balked at what they considered a low price for the company despite the deal having had the potential to be the largest inversion to date, but there have been plenty of other successful inversions involving multi-billion dollar valuations.

The pharmaceutical company Actavis (ACT) moved from New Jersey to Ireland by taking over Irish company Warner Chilcott in 2013, and then acquired Forest Labs of New York for $25 billion earlier this year. In December 2013, The Perrigo Company (PRGO) , the largest maker of private label over-the-counter medicines in the U.S., completed the acquisition of Elan Corporation for approximately $8.6 billion. The new combination will, undoubtedly, locate in Ireland, a move that would reduce its effective tax rate from 23.2 percent to 17percent and chalk up $150 million in annual savings. And Jazz Pharmaceuticals Inc. (JAZZ) moved from Palo Alto to Ireland after purchasing an Irish specialty drug maker Azur Pharma in 2011.

Taxes Motivating Overseas Moves

The “death and taxes” adage is appears to be applicable here. But while these companies can’t completely avoid paying taxes, they will certainly do whatever they can to avoid paying any more than they have to.

In the cases above, the companies all claimed that they would have more opportunities to further their international platform in a low-tax environment, especially via an Irish legal domicile (a territorial tax system) that would serve as an international hub. These transitions are made in the name of “protecting shareholders’ interests.” But is it true?

Takeovers by U.S. companies in low-tax environments have doubled in proportion to all overseas deals according to data compiled by Goldman Sachs Group Inc. analysts. The desire for such an arrangement, know as a tax inversion, is the main factor.

One big advantage of a tax inversion deal, except a lower statutory tax rate, is that deals can become more affordable. Once inverted, companies can more-easily use overseas cash to pay for a deal, and the earnings from any acquired company will also be taxed at the new lower rate.

As for Medtronic and Covidien, both companies have struggled to grow as hospitals and insurers push to control costs. In the U.S., the Affordable Care Act has put even more pressure on medical centers to work more efficiently and reduce repeat hospital admissions. Medtronic has struggled since 2010 with declining sales in its two major segments, including heart rhythm devices and spinal products for emerging questions about their safety and overuse.

“While the Covidien deal revolves around the tax advantages, Medtronic will gain by changing its legal residence to Dublin, that’s a part of a bigger strategy aimed at breaking loose from its historic dependence on heart pacemakers and defibrillators,” said Medtronic’s CEO Omar Ishrak in a conference.

Why Pharmaceutical Companies are on the Crest of this Wave

Similar transitions do happen in other industries. Global offshore contract driller Rowan Companies (RDC) moved its legal domicile to the United Kingdom in 2012, partially because the ability to remain competitive with the global effective tax rates of its peers. Insurance broker and consulting firm Aon Corp. (AON) moved from Chicago to London to be closer to the world’s largest insurance market and to benefit from a tax system where worldwide income is not taxed.

But why do so many of these deals involve pharma companies? These companies have seen years of consolidation among their customers, including hospitals and physician groups, and there has been a wave of mergers between hospital systems, as well as between hospitals and the practices of independent surgeons, over the past several years. As a result, hospitals have gained greater negotiating power with suppliers.

Pharma companies, in particular, prefer Ireland as their new home because the Green Isle boasts an encouraging tax regime for pharmaceutical manufacturers.

Another reason is that the Irish government provides a forum for good manufacturing practice-compliant sites with comparatively modest fees, a priority for most pharma companies looking to ensure cost-savings amid expiring patents.

Governments Unlikely to Stand Idle

The Irish government has begun to worry about the popularity of tax inversions. The country’s pillar of development policy may be used for purposes for which it was not intended, thus undermining Ireland’s insistence that it is not a tax haven and making it more difficult to defend its economic system in an international environment that is in the process of turning seriously against tax avoidance. The Irish authorities believe that the inversion trend is “push rather than pull”, implying that the high rate of U.S. tax rather than the low rate of Irish tax is driving the shift.

For the U.S., the trend threatens billions of dollars of tax revenues and raises “significant policy concerns,” in the words of the U.S. Treasury. Since 2010, U.S. purchases into the low-tax environments accounted for 15 percent of all overseas transactions with a value of $250 million or more, according to Goldman Sachs’ data. Without any changes in law, future deals will cost the U.S. an estimated $19.5 billion in tax revenue over the next 10 years.

As such, the federal government isn’t likely going to ignore these mergers forever. President Barack Obama has already made a proposal that would make inversion deals tougher. A U.S. company currently must buy a foreign company whose market value is at least 20 percent of the combined company, but President Obama’s proposal would raise that limit to 50 percent. In addition, Sen. Carl Levin (D-Mich.) and Senate Finance Chairman Ron Wyden (D-Ore.) both claimed in May that they plan to propose legislation that might curtail such deals.

Change in the Near Term Seems Unlikely

However, there’re little chances for doing any tax reform advancing in the near future. Any reform would likely have to include changing the rates paid by individuals and small businesses as well, and any changes to the tax system represent a political challenge that currently seems impossible to overcome.

In other words, companies like Medtronic and Covidien still have time to consider their escape from the U.S. tax system carefully.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for COV
PennyStock Zone
20 Dec 14 12:03:57
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
20 Dec 14 10:29:40
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszr3DgF $RFMD $IYT $MERC $GASL $COV $RH
stockroads
20 Dec 14 09:55:05
$BABA $BABY $BLL $CMN $COV, $CSX $GPK $JNS $LB $MNST $NAVI $NKE $NQ $ROST, $VRTX, http://t.co/fghUE0bgv4
PennyStock Zone
20 Dec 14 07:18:41
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
FinSentS SP500
20 Dec 14 07:17:17
$COV:US Covidien plc Declares Quarterly Dividend of $0.36 (COV) #COVIDIEN PLC http://t.co/AavuMtc2Tk #SP500
HotKeyTrading
20 Dec 14 06:00:03
Popular Stock Picks By Consensus: $COV $NKE $BBBY $MRK $GILD $BIDU $BRCD $NLY $ATVI $T $SYMC $AXP $MET $EMC $CMCSA http://t.co/Vv2VEnpBuv
PennyStock Zone
20 Dec 14 05:53:25
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
20 Dec 14 02:36:31
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
Maleah
20 Dec 14 01:56:27
*Review* How to Make Money in Stocks: http://t.co/CCyhDcgKgS $AREX $AGIO $CVX $FCAU $PKI $UAL $RFMD $IYT $MERC $GASL $COV $RH
Henriette Hostetler
20 Dec 14 00:09:33
Are you putting your money in $FRX $COV $APD $ABX View now http://t.co/zPUMe8LY3M
PennyStock Zone
19 Dec 14 23:33:18
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
FinSentS SP500
19 Dec 14 23:16:55
$COV:US Covidien plc Declares Quarterly Dividend of $0.36 (COV) #COVIDIEN PLC http://t.co/OtkP57TRnt #SP500
Mercedes Bullard
19 Dec 14 22:42:19
Stocks I'm keeping my Eye on...should you? $GLNG $COV $FL $PCLN Try this http://t.co/gVo3Wg6Ku1
PennyStock Zone
19 Dec 14 22:16:33
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
SBR China
19 Dec 14 22:08:21
RT @IrizarryMara: #Stocks you might want to buy $DOV $OXY $COV $IR #financialnews http://t.co/J9rOUINPP5
Mara Irizarry
19 Dec 14 21:42:50
#Stocks you might want to buy $DOV $OXY $COV $IR #financialnews http://t.co/J9rOUINPP5
Maleah
19 Dec 14 20:51:42
*Review* How to Make Money in Stocks: http://t.co/CCyhDcgKgS $AREX $AGIO $CVX $FCAU $PKI $UAL $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
19 Dec 14 20:41:42
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
Carletta Fisher
19 Dec 14 20:29:02
Todays Stocks you should be watching $TXN $COV $JNPR $RAX Give it a try http://t.co/vDRH6ou97d
Cyrus Abrams
19 Dec 14 20:08:02
#Stock Market Reports you need on $AMP $COV $GES $LGND Must have http://t.co/f5EuGOq9Uz
Prometheus Gillespie
19 Dec 14 20:02:36
The inversion trade is hammering John Paulson and other hedge funds, $SHPG $AGN $COV
Roxann Bayer
19 Dec 14 19:03:10
Are you looking for more winners like $BBY $GCI $COV $CBM View now http://t.co/ZeBuq7mbCq
Carletta Fisher
19 Dec 14 18:43:13
Stocks I'm keeping my Eye on...should you? $COV $CFN $SIRI $IR #singedinvestor http://t.co/SUrDYMqsYn
Leonie Machado
19 Dec 14 18:02:20
Latest information on #stocks like $FRT $IM $COV $BWP Goto http://t.co/oK1FTyQCpP
HotKeyTrading
19 Dec 14 18:00:04
Popular Stock Picks By Consensus: $COV $NKE $BBBY $MRK $GILD $BIDU $BRCD $NLY $ATVI $T $SYMC $AXP $MET $EMC $CMCSA http://t.co/Vv2VEnpBuv
Mariano Lehmann
19 Dec 14 17:56:11
Should you buy, sell or hold $COV $DF $THC $LGND I suggest http://t.co/MSsS3hDEPI
Rita Simpkins
19 Dec 14 17:09:40
Small-cap stocks breaking 52-wk high prices $COV $OMC $DLB $NUAN #financial http://t.co/ZRl3BHn5Kq
Dmitri Nabors
19 Dec 14 16:48:33
Insider Trading alerts on $JBHT $OXY $COV $CAG Click http://t.co/iboFFN34zp
Savanna Teel
19 Dec 14 16:38:46
Regretting your investment in $COV $PF $HON $QLYS #wallstreet http://t.co/tMOlqAFa6F
InterCooler
19 Dec 14 16:26:11
Covidien plc Declares Quarterly Dividend of $0.36 $COV http://t.co/Gw7JlDxhQu
Hilde Phipps
19 Dec 14 16:07:38
Get Free research on $LO $COV $FCX $DO #financial http://t.co/3Rab1YKgWw
Sol Tillery
19 Dec 14 16:04:14
Did you lose money on $COV $OV $VMC $FB #singedinvestor http://t.co/Q6HzovHFOw
FinSentS SP500
19 Dec 14 15:25:32
$COV:US Covidien Declares Quarterly Cash Dividend #COVIDIEN PLC http://t.co/ifaRFRalWI #SP500
Kimberlee Kerns
19 Dec 14 15:18:23
Whats going on with $COV $RDC $PLL $CI #money http://t.co/LSWafwMYXz
Maleah
19 Dec 14 14:33:54
*Review* How to Make Money in Stocks: http://t.co/CCyhDcgKgS $AREX $AGIO $CVX $FCAU $PKI $UAL $RFMD $IYT $MERC $GASL $COV $RH
US Banking News
19 Dec 14 13:47:20
Covidien plc announces quarterly dividend of $0.36. Payable on 1/16/2015. 1.40% Yield. http://t.co/NF3ycPWp3R $COV #COV
Covidien IR
19 Dec 14 13:44:01
$COV Covidien declares quarterly cash dividend... - http://t.co/jJD2NaQYG5
MarketCurrents
19 Dec 14 13:39:27
Covidien declares $0.36 dividend http://t.co/OorTr7eVOO $COV
ProTradersNews
19 Dec 14 13:33:09
$COV: Covidien Declares Quarterly Cash Dividend http://t.co/KSKh5rtQYt http://t.co/XRP1ju4frk
NASDAQ
19 Dec 14 13:31:55
$COV - Covidien Declares Quarterly Cash Dividend http://t.co/DgPsSuEFhD
Shena Fagan
19 Dec 14 12:51:10
Looking for research on $COV $ED $GIS $PCLN #StockMarket http://t.co/xuXA9tTaTZ
Shaquita Foy
19 Dec 14 12:13:16
Latest Earnings info on $DFS $LO $COV $USD Visit http://t.co/tPnQ6nLbCA
Brice Means
19 Dec 14 11:46:22
Dont want to lose like you did with $ALKS $DDD $COV $BLOX #liquidity http://t.co/SvzgR14e6L
PennyStock Zone
19 Dec 14 11:38:07
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
Thomas Collins
19 Dec 14 11:34:13
$COV Stock Update: Covidien plc (NYSE:COV) http://t.co/JADHWhgqHK
Alistair Zhang
19 Dec 14 11:27:28
#Stock Market Reports you need on $LLY $SEIC $COV $CADX #moneymanagement http://t.co/Qtgm32XnKZ
Alistair Perreault
19 Dec 14 09:56:11
Looking for more info on $COV $KLAC $AVGO $QLYS Must have http://t.co/oKZLn8zzvV
SmallCaps
19 Dec 14 09:44:12
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszr3DgF $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
19 Dec 14 09:15:44
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/37mHH9cdhB $RFMD $IYT $MERC $GASL $COV $RH
Sol Wentworth
19 Dec 14 08:14:27
Get Free research on $DFS $ADBE $COV $CAG I suggest http://t.co/VVBCpE7ZLK
				
				
By  +Follow June 18, 2014 3:00AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.